跳至主要内容
临床试验/NCT03346486
NCT03346486已完成不适用

Open, Fixed Sequence Diet-switch 4-week Intervention on the Effects of Brain-friendly Diet on Metabolic and Physiological Parameters and Cognitive Performance in Office Workers at Assumed Metabolic Risk

Fazer Group1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2017年8月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
88
试验地点
1
主要终点
Change in LDL cholesterol

研究概览

简要总结

To evaluate the effect of dietary intervention on metabolic risk profile, and on potential simultaneous changes in physiological and cognitive functions and to collect a unique database using state-of-the-art technologies on variables related to the above mentioned areas.

详细描述

The study is compiled from 4 phases: 1) a pilot study to evaluate performance and feasibility of the measurements and logistics for the BRAVE intervention study (N=10), 2) a pre-screening phase to select volunteers for the intervention study based on metabolite analyses (N=600), 3) the BRAVE intervention study as a controlled non-randomized open-label fixed sequence diet switch trial (N=88)and 4) a non-interventional reference group to estimate the learning effect due to repeated cognitive testing (N=30).

The Brainfood dietary regime is planned optimal for metabolism and cognitive function; having focus on regular meal frequency (breakfast, lunch and afternoon snack) and well-balanced light lunch at work -according to the so-called plate model and optimized recipes- will be provided.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed written informed consent
  • Age 18-65 years
  • Assumed metabolic risk based on pre-screening assessment of glucose and lipid metabolism related metabolites defined initially as being within the most impaired quartile with reference to available metabolite data-base from a comparable population. If recruitment efficiency requires, having a metabolic profile within the most impaired half instead of a quartile may be applied.
  • Male or female with at least 1/3 of the gender defined predominant among screened participants with assumed metabolic risk
  • Adequate Finnish or English skill to comprehend trial related instructions and questionnaires
  • Chest circumference of 75 to 115 cm (limits included)

排除标准

  • High probability to travel for more than one working day a week during the trial
  • Expected or planned major changes in lifestyle (diet, level of exercise, significant changes in work) or involved in the R&D of the measuring devices applied in the trial
  • Allergies restricting compliance with control or intervention diet (celiac disease, gluten free diet, stringent FODMAP diet)
  • Nickel allergy
  • History of unstable coronary artery disease (myocardial infarction, coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA), temporal ischemic attack within the previous 6 months
  • Diagnosed type 1 or type 2 diabetes requiring treatment
  • Inflammatory bowel disease or other intestinal or oesophageal disease requiring medical treatment or likely to have a nutritional affect
  • History of malignant diseases like cancer within five years prior to recruitment
  • Lipid lowering medication (statin, cholestyramine) or medication for obesity (orlistat, or liraglutide) or depression
  • Alcohol abuse (> 4 portion/per day) or recreational drug abuse
  • Pregnancy or planned pregnancy or lactating
  • Suspected low compliance according to the investigator's assessment

研究组 & 干预措施

Control diet

Placebo Comparator

Regular diet

干预措施: Control diet (Other)

Intervention diet

Active Comparator

Brainfood diet

干预措施: Intervention diet (Other)

结局指标

主要结局

Change in LDL cholesterol

时间窗: 8 weeks

Change in serum LDL concentration between control period and intervention period

次要结局

  • Change in serum metabolite concentrations(8 weeks)
  • Change in cognitive performance(4 weeks)
  • Changes in self-reported vigilance(4 weeks)
  • Changes in self-reported task load(4 weeks)
  • Daily pulse profile (evening- night- morning)(8 weeks)
  • Daily profile of heart rate variability (evening- night- morning)(8 weeks)
  • Number of adverse events(8 weeks)
  • Change in dietary habits and nutrient intake(8 weeks)

研究者

发起方
Fazer Group
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Dietary Intervention With Brain-friendly Diet | 临床试验